215 related articles for article (PubMed ID: 22911257)
1. Ventricular fractional shortening in 108 dogs with malignant lymphoma undergoing chemotherapy with a cyclic combination protocol including doxorubicin.
Tater G; Eberle N; Hungerbuehler S; Joetzke A; Nolte I; Wess G; Betz D
Tierarztl Prax Ausg K Kleintiere Heimtiere; 2012; 40(4):261-6. PubMed ID: 22911257
[TBL] [Abstract][Full Text] [Related]
2. Doxorubicin alone or in combination with asparaginase, followed by cyclophosphamide, vincristine, and prednisone for treatment of multicentric lymphoma in dogs: 121 cases (1987-1995).
Valerius KD; Ogilvie GK; Mallinckrodt CH; Getzy DM
J Am Vet Med Assoc; 1997 Feb; 210(4):512-6. PubMed ID: 9040837
[TBL] [Abstract][Full Text] [Related]
3. Treatment of dogs with lymphoma using a 12-week, maintenance-free combination chemotherapy protocol.
Simon D; Nolte I; Eberle N; Abbrederis N; Killich M; Hirschberger J
J Vet Intern Med; 2006; 20(4):948-54. PubMed ID: 16955821
[TBL] [Abstract][Full Text] [Related]
4. Evaluation of factors associated with second remission in dogs with lymphoma undergoing retreatment with a cyclophosphamide, doxorubicin, vincristine, and prednisone chemotherapy protocol: 95 cases (2000-2007).
Flory AB; Rassnick KM; Erb HN; Garrett LD; Northrup NC; Selting KA; Phillips BS; Locke JE; Chretin JD
J Am Vet Med Assoc; 2011 Feb; 238(4):501-6. PubMed ID: 21320021
[TBL] [Abstract][Full Text] [Related]
5. A combination chemotherapy protocol (VELCAP-L) for dogs with lymphoma.
Zemann BI; Moore AS; Rand WM; Mason G; Ruslander DM; Frimberger AE; Wood CA; L'Heureux DA; Gliatto J; Cotter SM
J Vet Intern Med; 1998; 12(6):465-70. PubMed ID: 9857340
[TBL] [Abstract][Full Text] [Related]
6. Evaluation of a multidrug chemotherapy protocol with mitoxantrone based maintenance (CHOP-MA) for the treatment of canine lymphoma.
Daters AT; Mauldin GE; Mauldin GN; Brodsky EM; Post GS
Vet Comp Oncol; 2010 Mar; 8(1):11-22. PubMed ID: 20230577
[TBL] [Abstract][Full Text] [Related]
7. Thirteen-week dose-intensifying simultaneous combination chemotherapy protocol for malignant lymphoma in dogs.
Zenker I; Meichner K; Steinle K; Kessler M; Hirschberger J
Vet Rec; 2010 Nov; 167(19):744-8. PubMed ID: 21257510
[TBL] [Abstract][Full Text] [Related]
8. Evaluation of a discontinuous treatment protocol (VELCAP-S) for canine lymphoma.
Moore AS; Cotter SM; Rand WM; Wood CA; Williams LE; London CA; Frimberger AE; L'Heureux DA
J Vet Intern Med; 2001; 15(4):348-54. PubMed ID: 11467592
[TBL] [Abstract][Full Text] [Related]
9. Evaluation of the results of a L-asparaginase-based continuous chemotherapy protocol versus a short doxorubicin-based induction chemotherapy protocol in dogs with malignant lymphoma.
Piek CJ; Rutteman GR; Teske E
Vet Q; 1999 Apr; 21(2):44-9. PubMed ID: 10321012
[TBL] [Abstract][Full Text] [Related]
10. Efficacy of a continuous, multiagent chemotherapeutic protocol versus a short-term single-agent protocol in dogs with lymphoma.
Simon D; Moreno SN; Hirschberger J; Moritz A; Kohn B; Neumann S; Jurina K; Scharvogel S; Schwedes C; Reinacher M; Beyerbach M; Nolte I
J Am Vet Med Assoc; 2008 Mar; 232(6):879-85. PubMed ID: 18341445
[TBL] [Abstract][Full Text] [Related]
11. Combination chemotherapy in feline lymphoma: treatment outcome, tolerability, and duration in 23 cats.
Simon D; Eberle N; Laacke-Singer L; Nolte I
J Vet Intern Med; 2008; 22(2):394-400. PubMed ID: 18312554
[TBL] [Abstract][Full Text] [Related]
12. Comparison of efficacy and toxicity of doxorubicin and mitoxantrone in combination chemotherapy for canine lymphoma.
Wang SL; Lee JJ; Liao AT
Can Vet J; 2016 Mar; 57(3):271-6. PubMed ID: 26933263
[TBL] [Abstract][Full Text] [Related]
13. Treatment of canine lymphoma with COPLA/LVP.
Boyce KL; Kitchell BE
J Am Anim Hosp Assoc; 2000; 36(5):395-403. PubMed ID: 10997514
[TBL] [Abstract][Full Text] [Related]
14. In vitro immune monitoring of antibody response in dogs given chemoimmunotherapy for lymphoma.
Jeglum KA; Winters WD; Young KM
Am J Vet Res; 1989 Apr; 50(4):488-92. PubMed ID: 2712415
[TBL] [Abstract][Full Text] [Related]
15. Gastrointestinal and hematologic adverse events after administration of vincristine, cyclophosphamide, and doxorubicin in dogs with lymphoma that underwent a combination multidrug chemotherapy protocol.
Tomiyasu H; Takahashi M; Fujino Y; Ohno K; Tsujimoto H
J Vet Med Sci; 2010 Nov; 72(11):1391-7. PubMed ID: 20543531
[TBL] [Abstract][Full Text] [Related]
16. Phase II clinical trial of combination chemotherapy with dexamethasone for lymphoma in dogs.
Greenberg CB; Boria PA; Borgatti-Jeffreys A; Raskin RE; Lucroy MD
J Am Anim Hosp Assoc; 2007; 43(1):27-32. PubMed ID: 17209082
[TBL] [Abstract][Full Text] [Related]
17. Assessment of cardiac troponin I (cTnI) and tissue velocity imaging (TVI) in 14 dogs with malignant lymphoma undergoing chemotherapy treatment with doxorubicin.
Tater G; Eberle N; Hungerbuehler S; Joetzke A; Nolte I; Wess G; Betz D
Vet Comp Oncol; 2017 Mar; 15(1):55-64. PubMed ID: 25664927
[TBL] [Abstract][Full Text] [Related]
18. Influence of a cyclic combination chemotherapeutic protocol on primary haemostasis in dogs suffering from malignant lymphoma.
Eberle N; Mischke R
Vet J; 2010 Mar; 183(3):298-304. PubMed ID: 19185520
[TBL] [Abstract][Full Text] [Related]
19. Evaluation of a multidrug chemotherapy protocol (ACOPA II) in dogs with lymphoma.
Myers NC; Moore AS; Rand WM; Gliatto J; Cotter SM
J Vet Intern Med; 1997; 11(6):333-9. PubMed ID: 9470157
[TBL] [Abstract][Full Text] [Related]
20. Chemotherapy versus chemotherapy with intralymphatic tumor cell vaccine in canine lymphoma.
Jeglum KA; Young KM; Barnsley K; Whereat A
Cancer; 1988 May; 61(10):2042-50. PubMed ID: 3359402
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]